Addex Therapeutics (ADXN) News Today $7.57 +0.19 (+2.57%) (As of 12:00 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest UpdateNovember 14, 2024 | americanbankingnews.comAddex Therapeutics: Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024November 12, 2024 | finanznachrichten.deAddex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024November 11, 2024 | globenewswire.com3 Growth Companies With High Insider Ownership On The SIX Swiss ExchangeOctober 12, 2024 | finance.yahoo.comBuy Rating Affirmed for Addex Therapeutics Amid Promising Clinical Developments and Strategic Neurosterix SpinoutOctober 3, 2024 | markets.businessinsider.comAddex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...October 1, 2024 | finance.yahoo.comAddex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateSeptember 30, 2024 | globenewswire.comAddex Therapeutics: Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitSeptember 20, 2024 | finanznachrichten.deAddex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitSeptember 19, 2024 | globenewswire.comAddex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comPositive Outlook for Addex Therapeutics: Significant Collaboration Payments and Promising Pipeline Drive Buy RatingAugust 28, 2024 | markets.businessinsider.comClinical Collaboration Ignites Addex Therapeutics (ADXN) Stock RallyAugust 28, 2024 | msn.comCrude Oil Dips; Addex Therapeutics Shares Spike HigherAugust 27, 2024 | benzinga.comAddex Therapeutics: Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAugust 27, 2024 | finanznachrichten.deJohnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use DisorderAugust 27, 2024 | finance.yahoo.comAddex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAugust 27, 2024 | globenewswire.comAddex Therapeutics Insider Ups Holding By 71% During YearAugust 19, 2024 | finance.yahoo.comCK Life Sciences Int'l., (Holdings) Inc. (LSI.F)August 15, 2024 | finance.yahoo.comBuy Rating Affirmed for Addex Therapeutics Amid Strategic Spinout and Promising Drug PipelineJuly 31, 2024 | markets.businessinsider.comAddex Therapeutics Ltd (APE1.MU)July 24, 2024 | sg.finance.yahoo.comAddex Therapeutics: Addex's Partner Discontinues ADX71149 development in EpilepsyJuly 22, 2024 | finanznachrichten.deAddex Therapeutics: Addex's Partner Janssen Pharma Discontinues ADX71149 development in EpilepsyJuly 22, 2024 | finanznachrichten.deAddex's Partner Discontinues ADX71149 development in EpilepsyJuly 22, 2024 | globenewswire.comAddex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)July 15, 2024 | globenewswire.comAddex To Present at the Thirteenth London International Cough Symposium (13th LICS)July 12, 2024 | globenewswire.comAddex Shareholders Approve All Resolutions at Annual General MeetingJuly 1, 2024 | globenewswire.comADXN Stock Earnings: Addex Therapeutics Reported Results for Q1 2024June 6, 2024 | investorplace.comAddex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateJune 6, 2024 | globenewswire.comAddex Convenes Annual General Meeting 2024June 5, 2024 | globenewswire.comAddex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024May 31, 2024 | globenewswire.comAddex to Present at Bio€quity Europe 2024May 8, 2024 | globenewswire.comAddex Therapeutics Ltd ADR ADXNMay 8, 2024 | morningstar.comTech Rally Subsides as US Equity Futures Waver Pre-BellApril 29, 2024 | msn.comAddex stock plunges 50% on failed study for epilepsy drugApril 29, 2024 | msn.comTrading was temporarily halted for "ADXN" at 10:04 AM with a stated reason of "LULD pause."April 29, 2024 | marketbeat.comAddex Therapeutics: Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyApril 29, 2024 | finanznachrichten.deAddex Provides Update on ADX71149 Phase 2 Epilepsy StudyApril 29, 2024 | globenewswire.comAddex to Present at the Swiss Biotech Day 2024April 19, 2024 | globenewswire.comADXN Stock Earnings: Addex Therapeutics Reported Results for Q4 2023April 18, 2024 | investorplace.comAddex Therapeutics GAAP EPS of -CHF 0.14, revenue of CHF 1.65MApril 18, 2024 | seekingalpha.comAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateApril 18, 2024 | globenewswire.comAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024April 11, 2024 | globenewswire.comNeurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological DisordersApril 3, 2024 | finanznachrichten.deAddex Announces Launch Of Neurosterix In Partnership With Perceptive - Quick FactsApril 3, 2024 | markets.businessinsider.comAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersApril 3, 2024 | globenewswire.comAddex to Present at the Bio-Europe Spring 2024 ConferenceMarch 14, 2024 | globenewswire.comAddex Therapeutics Stock (NASDAQ:ADXN), Short Interest ReportFebruary 22, 2024 | benzinga.comAddex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.January 31, 2024 | finance.yahoo.comAddex to Present at the Swiss Equities Baader ConferenceJanuary 9, 2024 | finance.yahoo.comAddex to Present at Biotech Showcase™ 2024January 5, 2024 | finance.yahoo.com Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO ADXN Media Mentions By Week ADXN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADXN News Sentiment▼0.980.47▲Average Medical News Sentiment ADXN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADXN Articles This Week▼01▲ADXN Articles Average Week Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Passage Bio News Acasti Pharma News LianBio News Lantern Pharma News Citius Pharmaceuticals News HCW Biologics News Surrozen News KALA BIO News BioLineRx News BioVie News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADXN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADXN Stock Alerts